Literature DB >> 35212534

Difluorobenzylamine Treatment of Organolead Halide Perovskite Boosts the High Efficiency and Stability of Photovoltaic Cells.

Qian-Qian Chu1,2,3, Zhijian Sun3, Yan Liu2, Hao Cui4, Bo Cheng1, Davoud Dastan3, Kyoung-Sik Moon3, Guan-Jun Yang2, Ching-Ping Wong3.   

Abstract

As one of the most competitive light-harvesting materials, organometal halide perovskites have attracted great attention due to their low-cost and top-down solution fabricability. However, the instability of perovskites in a moist environment reduces the potential for their commercialization. In this study, novel 2,4-fluorobenzylamine (FBA) was employed as the passivation material, which could successfully suppress the defects and improve the moisture resistance of perovskites, resulting in an ultrahigh power conversion efficiency of 17.6% for the carbon-based perovskite solar cells with good stability. Meanwhile, the whole process of interactions between the H2O molecule and the perovskite lattice was first elucidated by density functional theory calculations, which demonstrated the underlying mechanism of the improvement of moisture stability with the FBA treatment. This work opens up a new route toward addressing the main obstacles in the practical application of perovskite devices under ambient conditions.

Entities:  

Keywords:  carrier transport; defect density control; difluorobenzylamine passivation; high-performance perovskite solar cell; hydrophobic group

Year:  2022        PMID: 35212534     DOI: 10.1021/acsami.1c23292

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

1.  Experimental and Theoretical Studies on Optical Properties of Tetra(Imidazole) of Palladium (II) Phthalocyanine.

Authors:  Abdelmajid Timoumi; Davoud Dastan; Bassem Jamoussi; Khaled Essalah; Omar Hammed Alsalmi; Noureddine Bouguila; Henda Abassi; Radhouane Chakroun; Zhicheng Shi; Ştefan Ţălu
Journal:  Molecules       Date:  2022-09-20       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.